Why Amyris Stock Jumped Today
Shares of Amyris (NASDAQ: AMRS) were jumping 14.8% as of 3:43 p.m. EDT on Friday. The big gain came after the synthetic biology company announced encouraging in vivo (in the body) results from a study evaluating an intranasal RNA COVID-19 vaccine Amyris is developing with the Infectious Disease Research Institute.
Amyris said the results from the study found that its intranasal vaccine generates antibodies against SARS-CoV-2 and provides protection from upper respiratory infection by the virus. The company thinks the experimental vaccine could provide more protection against coronavirus variants than current messenger RNA vaccines do.
Image source: Getty Images.
Source Fool.com
